Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > This sounds pretty good to me

<< Previous

Bullboard Posts

Next >>

Comment by Fruckedagainon Jun 18, 2024 8:04pm

81 Views

Post# 36095145

RE:This sounds pretty good to me

They are sure buying a lot of stock....but then maybe they aren't because they don't want to lose the money they are being paid. Why be stupid?

Time for the head donkey to put out a new donkeyupdate for us shareholder donkeys.

Where is that rascal bioruns? i miss him.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project